Development of SPME method for concomitant sample preparation of rocuronium bromide and tranexamic acid in plasma

Journal of Pharmaceutical and Biomedical Analysis

Volumn 92, Issue , 2014, Pages 183-192

  Gorynski, Krzysztof ^a,b   Bojko, Barbara ^a,b   Kluger, Michael ^c   Jerath, Angela ^c,d   Wasowicz, Marcin ^c,d   Pawliszyn, Janusz ^a  

^a UNIVERSITY OF WATERLOO   (Canada)

^b NICOLAUS COPERNICUS UNIVERSITY   (Poland)

^c TORONTO GENERAL HOSPITAL   (Canada)

^d UNIVERSITY OF TORONTO   (Canada)

Author keywords

Liquid chromatography mass spectrometry; Quaternary ammonium drug; Rocuronium bromide; Tranexamic acid; Weak cation exchange solid phase microextraction (WCX SPME)

Indexed keywords

LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY; QUATERNARY AMMONIUM DRUG; ROCURONIUM BROMIDE; TRANEXAMIC ACID; WEAK CATION EXCHANGE SOLID-PHASE MICROEXTRACTION (WCX-SPME);

ANDROSTANOLS; CHROMATOGRAPHY, LIQUID; HUMANS; REPRODUCIBILITY OF RESULTS; SOLID PHASE MICROEXTRACTION; TANDEM MASS SPECTROMETRY; TRANEXAMIC ACID;

EID: 84893830658     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2014.01.026     Document Type: Article

References (38)

1. Tuba Z., Maho S., Vizi E.S. Synthesis and structure-activity relationships of neuromuscular blocking agents. Curr. Med. Chem. 2002, 9:1507-1536.
2. Muir A.W., Houston J., Green K.L., Marshall R.J., Bowman W.C., Marshall I.G. Effects of a new neuromuscular blocking agent (Org 9426) in anaesthetized cats and pigs and in isolated nerve-muscle preparations. Br. J. Anaesth. 1989, 63:400-410.
3. Atherton D.P., Hunter J.M. Clinical pharmacokinetics of the newer neuromuscular blocking drugs. Clin. Pharmacokinet. 1999, 36:169-189.
4. Sorgenfrei I.F., Norrild K., Larsen P.B., Stensballe J., Ostergaard D., Prins M.E., Viby-Mogensen J. Reversal of rocuronium-induced neuromuscular block by the selective relaxant binding agent sugammadex: a dose-finding and safety study. Anesthesiology 2006, 104:667-674.
5. Sparr H.J., Beaufort T.M., Fuchs-Buder T. Newer neuromuscular blocking agents: how do they compare with established agents?. Drugs 2001, 61:919-942.
6. Saldien V., Vermeyen K.M., Wuyts F.L. Target-controlled infusion of rocuronium in infants, children, and adults: a comparison of the pharmacokinetic and pharmacodynamic relationship. Anesth. Analg. 2003, 97:44-49.
7. Fernández-Candil J., Gambús P.L., Trocóniz I.F., Valero R., Carrero E., Bueno L., Fábregas N. Pharmacokinetic-pharmacodynamic modeling of the influence of chronic phenytoin therapy on the rocuronium bromide response in patients undergoing brain surgery. Eur. J. Clin. Pharmacol. 2008, 64:795-806.
8. Staals L.M., Snoeck M.M., Driessen J.J., van Hamersvelt H.W., Flockton E.A., van den Heuvel M.W., Hunter J.M. Reduced clearance of rocuronium and sugammadex in patients with severe to end-stage renal failure: a pharmacokinetic study. Br. J. Anaesth. 2010, 104:31-39.
9. Matteo R.S., Ornstein E., Schwartz A.E., Ostapkovich N., Stone J.G. Pharmacokinetics and pharmacodynamics of rocuronium (Org 9426) in elderly surgical patients. Anesth. Analg. 1993, 77:1193-1197.
10. Gao L., Ramzan I., Baker B. Rocuronium plasma concentrations during three phases of liver transplantation: relationship with early postoperative graft liver function. Br. J. Anaesth. 2002, 88:764-770.
11. van Miert M.M., Eastwood N.B., Boyd A.H., Parker C.J., Hunter J.M. The pharmacokinetics and pharmacodynamics of rocuronium in patients with hepatic cirrhosis. Br. J. Clin. Pharmacol. 1997, 44:139-144.
12. Ezzine S., Varin F. Interstitial muscle concentrations of rocuronium under steady-state conditions in anaesthetized dogs: actual versus predicted values. Br. J. Anaesth. 2005, 94:49-56.
13. Woloszczuk-Gebicka B., Wyska E., Grabowski T., Swierczewska A., Sawicka R. Pharmacokinetic-pharmacodynamic relationship of rocuronium under stable nitrous oxide-fentanyl or nitrous oxide-sevoflurane anesthesia in children. Paediatr. Anaesth. 2006, 16:761-768.
14. Kleef U.W., Proost J.H., Roggeveld J., Wierda J.M. Determination of rocuronium and its putative metabolites in body fluids and tissue homogenates. J. Chromatogr. 1993, 621:65-76.
15. Błazewicz A., Fijałek Z., Warowna-Grześkiewicz M., Boruta M. Simultaneous determination of rocuronium and its eight impurities in pharmaceutical preparation using high-performance liquid chromatography with amperometric detection. J. Chromatogr. A 2007, 1149:66-72.
16. Ariffin M.M., Anderson R.A. LC/MS/MS analysis of quaternary ammonium drugs and herbicides in whole blood. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2006, 842:91-97.
17. Cirimele V., Villain M., Pépin G., Ludes B., Kintz P. Screening procedure for eight quaternary nitrogen muscle relaxants in blood by high-performance liquid chromatography-electrospray ionization mass spectrometry. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2003, 789:107-113.
18. Farenc C., Enjalbal C., Sanchez P., Bressolle F., Audran M., Martinez J., Aubagnac J.L. Quantitative determination of rocuronium in human plasma by liquid chromatography-electrospray ionization mass spectrometry. J. Chromatogr. A 2001, 910:61-67.
19. Tang F.P., Leung G.N., Wan T.S. Analyses of quaternary ammonium drugs in horse urine by capillary electrophoresis-mass spectrometry. Electrophoresis 2001, 22:2201-2209.
20. Ho E.N., Kwok W.H., Wong A.S., Wan T.S. Detection of singly- and doubly-charged quaternary ammonium drugs in equine urine by liquid chromatography/tandem mass spectrometry. Anal. Chim. Acta 2012, 710:94-101.
21. Gutteck-Amsler U., Rentsch K.M. Quantification of the aminosteroidal non-depolarizing neuromuscular blocking agents rocuronium and vecuronium in plasma with liquid chromatography-tandem mass spectroscopy. Clin. Chem. 2000, 46:1413-1414.
22. Mallet C.R., Lu Z., Mazzeo J.R. A study of ion suppression effects in electrospray ionization from mobile phase additives and solid-phase extracts. Rapid Commun. Mass Spectrom. 2004, 18:49-58.
23. Vuckovic D., Zhang X., Cudjoe E., Pawliszyn J. Solid-phase microextraction in bioanalysis: new devices and directions. J. Chromatogr. A 2010, 1217:4041-4060.
24. Bojko B., Cudjoe E., Wasowicz M., Pawliszyn J. Solid-phase microextraction. How far are we from clinical practice. TrAC Trend Anal. Chem. 2011, 30:1505-1512.
25. Bojko B., Cudjoe E., Gómez-Ríos G.A., Gorynski K., Jiang R., Reyes-Garcés N., Risticevic S., Silva E.A., Togunde O., Vuckovic D., Pawliszyn J. SPME-quo vadis?. Anal. Chim. Acta 2012, 750:132-151.
26. Musteata F.M., Musteata M.L., Pawliszyn J. Fast in vivo microextraction: a new tool for clinical analysis. Clin. Chem. 2006, 52:708-715.
27. Lord H.L., Zhang X., Musteata F.M., Vuckovic D., Pawliszyn J. In vivo solid-phase microextraction for monitoring intravenous concentrations of drugs and metabolites. Nat. Protoc. 2011, 6:896-924.
28. Mirnaghi F.S., Chen Y., Sidisky L.M., Pawliszyn J. Optimization of the coating procedure for a high-throughput 96-blade solid phase microextraction system coupled with LC-MS/MS for analysis of complex samples. Anal. Chem. 2011, 83:6018-6025.
29. Ouyang G., Pawliszyn J. A critical review in calibration methods for solid-phase microextraction. Anal. Chim. Acta 2008, 627:184-197.
30. Bojko B., Vuckovic D., Cudjoe E., Hoque M.E., Mirnaghi F., Wasowicz M., Jerath A., Pawliszyn J. Determination of tranexamic acid concentration by solid phase microextraction and liquid chromatography-tandem mass spectrometry: first step to in vivo analysis. J. Chromatogr. B: Analyt. Technol. Biomed. Life Sci. 2011, 879:3781-3787.
31. Bojko B., Vuckovic D., Mirnaghi F., Cudjoe E., Wasowicz M., Jerath A., Pawliszyn J. Therapeutic monitoring of tranexamic acid concentration: high-throughput analysis with solid-phase microextraction. Ther. Drug Monit. 2012, 34:31-37.
32. Dunn C.J., Goa K.L. Tranexamic acid: a review of its use in surgery and other indications. Drugs 1999, 57:1005-1032.
33. Matuszewski B.K., Constanzer M.L., Chavez-Eng C.M. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 2003, 75:3019-3030.
34. Food and Drug Administration Guidance for Industry: Bioanalytical Method Validation 2001, Department of Health and Human Services, FDA, Center for Drug Evaluation and Research, Rockville, MD.
35. (accessed 05.2013). http://www.drugbank.ca/.
36. Yiu K.C.H., Ho E.M.N., Wan T.S.M. Detection of quaternary ammonium drugs in equine urine by liquid chromatography-mass spectrometry. Chromatographia 2004, 59:S45-S50.
37. Mirnaghi F.S., Pawliszyn J. Reusable solid-phase microextraction coating for direct immersion whole-blood analysis and extracted blood spot sampling coupled with liquid chromatography-tandem mass spectrometry and direct analysis in real time-tandem mass spectrometry. Anal. Chem. 2012, 84:8301-8309.
38. Zemuron Product Information, Merck & Co., Inc., USA. (accessed 08.2013). http://www.merck.com/product/usa/pi_circulars/z/zemuron/zemuron_pi.pdf.